Deadline: 10-Aug-2026
The Sushruta Arogya Samman invites applications from interdisciplinary teams in India that are developing validated life sciences innovations with potential for clinical or real-world implementation. The award recognises teams that have moved beyond the concept stage and demonstrated scientific validation, translational progress, and a clear pathway toward healthcare impact and large-scale deployment.
About the Sushruta Arogya Samman
The Sushruta Arogya Samman is part of the Bharat Life Sciences Award platform, an initiative created to recognise and accelerate excellence within India’s life sciences ecosystem.
The award is organised by FICCI and powered by Lilly, with guidance from an expert Advisory Council and an independent jury.
The platform aims to celebrate innovators, researchers, teams, and institutions that contribute to scientific advancement and create meaningful public health outcomes aligned with India’s research and innovation priorities.
Objectives of the Award
The Sushruta Arogya Samman aims to:
- Recognise breakthrough life sciences innovations.
- Support teams developing healthcare solutions beyond early concepts.
- Encourage translational research and implementation.
- Promote innovations with measurable public health impact.
- Accelerate deployment and scaling of healthcare solutions in India.
Focus Areas
The award supports interdisciplinary teams working on innovations involving:
- Life sciences research.
- Healthcare technologies.
- Translational medicine.
- Clinical development.
- Pre-clinical research.
- Real-world healthcare applications.
- Evidence-based health solutions.
Projects should demonstrate progress through stages such as:
- Validation.
- Pre-clinical development.
- Clinical advancement.
- Translational implementation.
- Real-world deployment.
Eligibility Criteria
Applicants must meet the following requirements:
- The applicant must be an interdisciplinary team.
- The team must have at least three members.
- The team must be affiliated with an institution registered and operating in India.
- The majority of research work or key contributions must have been carried out in India.
Teams must demonstrate:
- Progress beyond the concept stage.
- Scientific or technical validation.
- Evidence of advancement toward implementation.
- A clear pathway for deployment, scaling, or broader application.
Regulatory and Ethical Requirements
For projects involving:
- Human participants.
- Animal studies.
- Clinical data.
Applicants must provide relevant documentation, including:
- Institutional Ethics Committee approvals.
- Regulatory permissions.
- Clinical trial registration details, where applicable.
Award Grant
The winner of the Sushruta Arogya Samman will receive:
- INR 1.5 Crore grant
The funding will support continued development, advancement, and implementation of the winning innovation.
Selection Process
Applications will undergo evaluation through:
- An independent jury review.
- Expert assessment.
- Transparent evaluation procedures.
The assessment will consider:
- Innovation quality.
- Scientific validation.
- Translational progress.
- Real-world impact potential.
- Scalability and implementation pathway.
Frequently Asked Questions (FAQs)
What is the Sushruta Arogya Samman?
The Sushruta Arogya Samman is an award recognising interdisciplinary teams in India that develop validated life sciences innovations with potential for clinical or real-world application.
Who can apply for this award?
Interdisciplinary teams affiliated with institutions registered and operating in India can apply.
How many members should the team have?
The team must include a minimum of three members.
Are individual researchers eligible to apply?
No. The award is designed specifically for interdisciplinary teams rather than individual applicants.
What type of innovations are eligible?
Eligible innovations should belong to the life sciences and healthcare sectors and must have progressed beyond the concept stage.
What does “beyond the concept stage” mean?
It means the innovation should have demonstrated validation, testing, development progress, or evidence showing potential for practical implementation.
What evidence must teams provide?
Teams should provide evidence of:
- Validation results.
- Research progress.
- Development milestones.
- Pathway toward real-world use or scaling.
What is the prize amount?
The winning team will receive a grant of INR 1.5 Crore.
Who organises the Bharat Life Sciences Award platform?
The platform is organised by FICCI and powered by Lilly, with oversight from an Advisory Council and independent jury.
Are regulatory approvals required?
Yes. Projects involving humans, animals, or clinical data must provide required ethics approvals, regulatory clearances, and registrations where applicable.
Can innovations still in the idea stage apply?
No. The award focuses on validated innovations that have moved beyond early conceptual development.
Conclusion
The Sushruta Arogya Samman provides recognition and financial support to interdisciplinary teams advancing impactful life sciences innovations in India. By rewarding validated solutions with clear implementation pathways, the award aims to accelerate healthcare innovation and strengthen India’s life sciences ecosystem.
For more information, visit FICCI.